HomeInsightsMarket Capitalization

Market Capitalization of Krebs Biochemicals & Industries Ltd

Market Capitalization of Krebs Biochemicals & Industries Ltd

stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

1.6 K

stocks traded

Last Updated time: 05 Nov 9.00 AM

Image

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO

MARKETCAP

180.57 crore

Last updated on: Nov 04, 2024

Key Highlights

  • The Market Cap of Krebs Biochemicals & Industries Ltd is ₹ 180.57 crore as of 04 Nov 24.
  • The Market Cap of Krebs Biochemicals & Industries Ltd changed from ₹ 192.91 crore on March 2019 to ₹ 131.56 crore on March 2024 . This represents a CAGR of -6.18% over 6 years. .
  • The Latest Trading Price of Krebs Biochemicals & Industries Ltd is ₹ 83.75 as of 04 Nov 15:30.

Historical Market Cap of Krebs Biochemicals & Industries Ltd

No data available

* All values are in crore

Company Fundamentals for Krebs Biochemicals & Industries Ltd

No data available

Image

Krebs Biochemicals & Industries Ltd

NSE: KREBSBIO

PRICE

83.75

0.35 (0.42%)

stock direction

Last updated on: Nov 04 03:30 PM

Market price Over Time

1M

1Y

3Y

5Y

Monitoring Krebs Biochemicals & Industries Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPriceleft
04 Nov 202483.75
01 Nov 202483.4
31 Oct 202480
30 Oct 202479.86
29 Oct 202478
28 Oct 202480.99
25 Oct 202478.05
24 Oct 202479.64
23 Oct 202481.26
22 Oct 202482.91

SWOT Analysis Of Krebs Biochemicals & Industries Ltd

Strength

0

S

Weakness

1

W

Opportunity

0

O

Threats

0

T

BlinkX Score for Krebs Biochemicals & Industries Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Krebs Biochemicals & Industries Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of Market Cap

Key Valuation Metric of Krebs Biochemicals & Industries Ltd

No data available

Historical P/E Ratio of Krebs Biochemicals & Industries Ltd

No data available

* All values are in %

Historical Revenue of Krebs Biochemicals & Industries Ltd

No data available

* All values are in crore

Historical EBITDA of Krebs Biochemicals & Industries Ltd

No data available

* All values are in crore

Historical Net Profit of Krebs Biochemicals & Industries Ltd

No data available

* All values are in crore

Historical Dividend Payout of Krebs Biochemicals & Industries Ltd

No data available

* All values are in %

About Krebs Biochemicals & Industries Ltd

  • Krebs Biochemicals & Industries Ltd (Formerly Krebs Biochemicals Ltd), promoted by R T Ravi in 1991 is engaged in the manufacture of Active Pharmaceutical Ingredients(API) through Fermentation process, one among very few in the world to do the same. Krebs develops commercially viable biotech processes for application in medicine, agriculture and industry.
  • Undertaking contract manufacturing for large pharmaceutical and multinational companies and developing products for sale in global markets, the Company possesses expertise and infrastructure in chemical synthesis, fermentation and enzymatic technologies. KBIL which commenced commercial operations in the year 1994 with an installed capacity of 60 TPA has now grown to 150 TPA. KBL went to public with an IPO in 1994. During 2001-02, the company launched Vitamin C(I P Grade) through Fermentation Process.

Krebs Biochemicals & Industries Ltd News Hub

News

Krebs Biochemicals & Industries to conduct board meeting

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

29 Oct 202414:40

News

Krebs Biochemicals & Industries schedules AGM

Krebs Biochemicals & Industries announced that the 32th Annual General Meeting (AGM) of th...

Read more

09 Sep 202410:11

News

Krebs Biochemicals & Industries to announce Quarterly Result

Krebs Biochemicals & Industries will hold a meeting of the Board of Directors of the Compa...

Read more

22 Jul 202410:35

News

Krebs Biochemicals & Industries Ltd leads gainers in 'B' group

North Eastern Carrying Corporation Ltd, Capital Trust Ltd, Kilitch Drugs (India) Ltd and G...

Read more

19 Jul 202412:15

News

Krebs Biochemicals & Industries Ltd leads gainers in 'B' group

Remedium Lifecare Ltd, Mahanagar Telephone Nigam Ltd, Coastal Corporation Ltd and Quick He...

Read more

18 Jul 202412:15

News

Krebs Biochemicals & Industries Ltd leads gainers in 'B' group

Shreyans Industries Ltd, Alphageo (India) Ltd, Coral India Finance & Housing Ltd and IVP L...

Read more

08 Jul 202412:16

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

FAQs for Krebs Biochemicals & Industries Ltd Market Cap

What is the market cap of Krebs Biochemicals & Industries Ltd?

As of November 5, 2024, Krebs Biochemicals & Industries Ltd has a market capitalization of ₹180.57, however, this figure is subject to change due to fluctuations in its stock price and market conditions.

What factors influence Krebs Biochemicals & Industries Ltd's market capitalization?

Krebs Biochemicals & Industries Ltd's market capitalization is influenced by factors such as its financial performance, and the company’s ability to innovate and adapt to market trends. Moreover, macroeconomic factors like economic conditions, currency fluctuations, and global automotive industry trends also affect its market capitalization.

Can market capitalization be used to predict future stock performance of Krebs Biochemicals & Industries Ltd?

Market capitalization alone is not a reliable predictor of future stock performance, as it reflects the current value of a company's equity rather than its future potential. To forecast %s's future stock performance, investors should consider additional factors such as financial health, growth prospects, industry trends, and broader economic conditions.

How often does Krebs Biochemicals & Industries Ltd's market capitalization change?

Krebs Biochemicals & Industries Ltd's market capitalization can change frequently, within a single trading day, due to fluctuations in stock price. These changes are influenced by market conditions, investor sentiment, company performance, and broader economic factors. Therefore, tracking its market capitalization requires continuous monitoring of stock price movements and related financial news.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199*